Main Industry
Health Care
Main Product/Service
Novel Drugs for Diabetes Treatment and Cancer Medications
(The content above was translated by AI.)
(The content above was translated by AI.)
Founded Year
2014
Unified Business No.
24762324
Status
Closed
Number of Employees
0
Total Paid-in
Capital
0 (NT$)
Location of Company
Taiwan
, Taipei City
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
VITNOVO, INC. is a biopharmaceutical company dedicated to the development and commercialization of novel therapeutic drugs. The company's development projects all possess the advantages of addressing urgent medical needs and market opportunities. Its flagship products include novel diabetes drugs and cancer drugs that combine imaging molecules with specific cancer-targeting capabilities and highly effective chemotherapeutic drugs to establish brand-new products that are superior to original conventional drugs.
(The content above was translated by AI.)
(The content above was translated by AI.)
